Material and Methods: this study comprised of 50 patients with their first alcoholic pancreatitis and 50 alcoholic controls with no history of pancreatitis but similar alcohol use recruited from an alcohol rehabilitation center.Helicobacter infection was measured using enzygnost eia igG-test. complications and length of hospital stay were also recorded in patients with alcoholic pancreatitis.
In Finland, alcohol is the most common etiological factor,a ccounting for about 70% of all AP (4) . The cellular mechanisms and inflammatory responses of acute pancreatitis have recently been reviewed (11, 12) .
Even though heavy alcohol use has been shown to be a clear risk factor for AP, the exact pathophysiological mechanism triggering the onset of alcohol induced acute pancreatitis (AIAP) remains unclear. Most heavy alcohol consumers do not develop pancreatitis -only 2-3% even in the group of the highest alcohol intake may develop an AP during a [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] year follow up period (13) .
Helicobacter pylori (HP) has been shown to be the most important causative agent in peptic and duodenal ulcer formation (14) , and has been clearly linked
INTrODUCTION
The worldwide incidence of acute pancreatitis (AP) ranges from 5t om oret han 100 per 100 000 patient years (1) (2) (3) (4) (5) (6) (7) . The proportions of the two most common etiological factors, alcohol and gallstones, vary considerably in different countries and regions (3, (8) (9) (10) .
to increased risk of gastric cancer (15) . The prevalence of HP in Finland is similar with other industrialized nations, being 6-70%, depending on the age of the cohort studied (16, 17) . recently Domínguez-Muñoz et al (18) showed that the interdigestive exocrine pancreatic secretion and postprandial release of gastrin werei ncreased in HP positive subjects. Manes et al (19) reviewed studies addressing HP and pancreatic diseases and the mechanisms through which HP might affect pancreatic physiology. In summary, release of ammonia and lipopolysaccharides, activation of leukocytes and subsequent release of proinflammatory cytokines together with hypergastrinemia and duodenal acidification associated with HP infection might trigger or modulate AIAP, but the association has not been previously extensively studied.
Furthermore, it was unexpectedly suggested that the prevalence of HP infection was lower in patients suffering from their first episode of AIAP compared to an age and alcohol consumption matched control group of alcoholics with no history of AP (20) . This was, however,ap ilot study addressing ad ifferent question with very low sample sizes. The aim of this study was to compareH Ps eropositivity between AIAP patients and alcoholics with no history of AIAP. We hypothesized that the seroprevalence of HP would considerably differ between the two groups, which might suggest that HP infection has an effect on the development of AP.F urthermore, we also studied the association between the seropositivity and the severity of AIAP and the length of hospital stay.
MATErIAl AND METHODS
Based on the previous study (20) , we expected prevalences of about 10% and 40%, for HP infection in the AIAP-patients and alcoholics with no history of AIAP,respectively. When the power was set at 90% and alpha at 0.05, a sample size of 100 (n =5 0 for both groups) was calculated to be required (21) .
This study was performed as ar etrospective analysis of previously collected serum samples in a prospective study (22) . Our study subjects werer ecruited between January 2001 and November 2005. The first group consisted of 50 patients hospitalized for their first AIAP attack. Their serum samples were obtained during the hospitalization. AP was diagnosed when the patient experienced epigastric pain resulting in hospitalization and had the clinical signs consistent with AP together with serum amylase activity of at least three times the upper normal range and elevated inflammation markers (serum C-reactive protein concentration and/or blood leukocyte count) and/or the radiologic findings of AP during hospitalization. AP was considered as alcohol induced (23) when other etiological factors were excluded by laboratory testing and imaging and the patient reported high consumption of alcohol in the Alcohol Use Disorders Identification Test (AUDIT), or by further interviewing of the patient in the two cases with 7o rl ess points in the AUDIT test. The patients had not reported to be treated for abdominal complaints previously.
AP was considered severe when it met with the Atlanta criteria (24) . Basic information, such as age, gender and Body Mass Index (BMI) were recorded. The length of hospital stay,need and lenght of intensive careunit treatment and the development of complications were recorded. Al-cohol use, including the length of the last drinking session prior to AIAP attack, was measured by interviewing the patients. This was performed by ap erson specialized to dependence problems.
Thec ontrol group consisted of 50 alcoholics recruited from an alcohol detoxification centrewhose serum samples were obtained during their stay in the centre. We matched the control group according to age and reported amount of alcohol use. None of the control subjects had ah istory of AP.
The median age in the AIAP group was 45 years (range 18-73). The group consisted of 38 males and 12 females. The median AUDIT score was 22 (range 5-38) and the median BMI was 26 (range 19-34). likewise, the median age in the control group was 46 (range 21-66) and the group consisted of 31 males and 19 females. The median AUDIT scorew as 28 (range 15-36) and the median BMI was 25 (range [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] .
The serum samples werestored frozen in -70°C the time between their acquisition and analysis. The samples were analysed using acommercial Enzygnost Anti-Helicobacter pylori II/IgG EIA kit (Dade Behring) with a cut-off value of 10 U/ml. The reported sensitivity and specificity by the manufacturer were 93.4% and 98.8%, respectively.
Statistical testing was performed with the SPSS statistical software using Pearsons correlation, the Chi-Square test, Mann-Whitney U-test and Fisher's Exact test. Pvalues ≤0.05 were considered significant. This study was performed according to the Helsinki declaration and was approved by the Ethical Committee of Tampere University Hospital.
rESUlTS
Both groups were high alcohol consumers and there were no significant differences in the age, gender distribution or BMI between the two groups. Tenout of 50 (20%; 95% CI 9-31%) in the AIAP group and 15 out of 50 (30%; 95% CI 17-43%) in the control group tested positive for HP,p=0 .248. Thus HP serology did not differ significantly between the study groups. HP was not associated with the reported amount of alcohol use in either group.
Them edian length of hospital stay for all AIAP patients was 7 (range 3-47) days. Two patients, both HP negative, required intensive care unit treatment. The median length of hospitalstayfor patients tested negative was 6 (range 3-47) days and 11 (range 6-25) days for patients tested positive for HP,p=0.013. Ten out of 50 (20%) patients had a severe pancreatitis according to the Atlanta criteria. There were no mortalities. Four out of ten (40%) patients seropositive for HP had as everep ancreatitis compared to six out of 40 (15%) patients negative for HP (Or3 .78 [95% CI 0.815-17.52], p=0.097). In HP positive patients, two patients had necrotizing pancreatitis, one patient developed a pancreatic abscess and one pancreatic pseudocysts. In HP negative patients, four patients had necrotizing pancreatitis, one of which also developed ap seudocyst, one had respiratory failurea nd developed ap seudocyst and one later developed pseudocysts. Therew as no statistically significant correlation between HP serology and the development of individual complications. The median peak C-reactive protein concentration during the first days after admission in all patients was 168mg/land was significantly increased in patients with severe pancreatitis, 307mg/l vs. 164mg/l, p=0.010. The respective figures for patients positive and negative for HP were 213mg/l and 166mg/l, p=0.576.
The median age for patients tested positive and negative for HP, was 48 and 44 (p =0.096) in the AIAP group and 46 and 46 (p =0.589) in the control group, respectively.r eported alcohol use, age, nor BMI, werea ssociated with the length of the hospital stay, or other markers of severity studied.
DISCUSSION
We sought to evaluate whether the prevalence of HP seropositivity differs between AIAP patients with their first AIAP and alcoholics with no history of AIAP and could thus be af actor affecting the onset of AIAP.F urthermore, we compared the course and length of hospital stay in AIAP patients according to HP serology.
We obtained the prevalence of HP by measuring the IgG-class antibodies from the sera of the patients. The Enzygnost test itself has been validated by other authors, reporting sensitivities and specificities of 79-93% and 79-100%, respectively (25) (26) (27) . Freezing and thawing of the serum samples should not affect the results (28) . Because the titers remain elevated for several months to years after the eradication of HP (29, 30) we could eliminate the confounding factors associated with the treatment of AIAP, such as possible use of antibiotics and proton pump inhibitors during the acute course of the disease. Thus the seropositivity should reflect the situation preceding the onset of AIAP.W hile it would have been optimal to include the urea breath test, stool antigen, or histology analysis in addition to serology,t hey weren ot included in the original study, and due to the retrospective setting of this study,could not be performed. Spontaneus healing of HP infection is rare ( 31, 32) and therefore is unlikely to affect the results. The patients did not report recent treatment of HP, but of course it is possible that some had undergone such therapy without proper recognition. However, we anticipate that if such had happened, it would have happened at the same rate both in the study group and the control group.
The seroprevalence of HP in this study was 20% in AIAP patients and 30% in alcoholics with no history of AIAP, p=0.248. This difference was much less than in the earlier pilotstudy (20) , andsuggests that HP is not associated with AIAP in such quantity,t hat it would be ac linically significant determinant in the genesis of AIAP. To establish this difference (20% vs. 30%) significantly in the seroprevalence of HP between the two groups with 90% power would have required as ample size of 820 patients. Despite the possible statistical significance then found, the clinical significance of such a small difference would still have remained minimal.
The median length of hospital stay was somewhat long in our study,7days, though most cases werenot severe according to the Atlanta criteria. The relatively high median peak C-reactive protein concentrations also indicate at least intermediate severity of most cases while actual organ failure was rare in our population. The long hospital stay was mostly due to pain management and difficulties in eating.
HP was associated with a somewhat extended hospital stay. This was possibly due to the slight albeit not significant association between the severity of AIAP and HP seropositivity. HP positive patients also had somewhat increased median peak C-reactive protein concentration, but the difference was not statistically significant. However,b ased on these results, it is impossible to determine whether HP is affecting the pathophysiology of AIAP or whether this suggested association with the length of stay is just a coincident. There is also a possibility that some cofactor exists that disposes patients to both HP seropositivity and somewhat more severe AIAP. Therefore a separate study addressing primarily the association of HP and the severity of AP is required to answer this question.
In conclusion this study suggests that HP infection is not clinically significantly associated with the development of AIAP.H owever,H P infection might prolong the length of hospital stay due to more severe disease, which needs to be further investigated.
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